Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Metabolic landscape of the healthy pancreas and pancreatic tumor microenvironment
Monica E. Bonilla, Megan D. Radyk, Matthew D. Perricone, Ahmed M. Elhossiny, Alexis C. Harold, Paola I. Medina-Cabrera, Padma Kadiyala, Jiaqi Shi, Timothy L. Frankel, Eileen S. Carpenter, Michael D. Green, Cristina Mitrea, Costas A. Lyssiotis, Marina Pasca di Magliano
Monica E. Bonilla, Megan D. Radyk, Matthew D. Perricone, Ahmed M. Elhossiny, Alexis C. Harold, Paola I. Medina-Cabrera, Padma Kadiyala, Jiaqi Shi, Timothy L. Frankel, Eileen S. Carpenter, Michael D. Green, Cristina Mitrea, Costas A. Lyssiotis, Marina Pasca di Magliano
View: Text | PDF
Research Article Oncology

Metabolic landscape of the healthy pancreas and pancreatic tumor microenvironment

  • Text
  • PDF
Abstract

Pancreatic cancer, one of the deadliest human malignancies, is characterized by a fibro-inflammatory tumor microenvironment and wide array of metabolic alterations. To comprehensively map metabolism in a cell type–specific manner, we harnessed a unique single-cell RNA-sequencing dataset of normal human pancreata. This was compared with human pancreatic cancer samples using a computational pipeline optimized for this study. In the cancer cells we observed enhanced biosynthetic programs. We identified downregulation of mitochondrial programs in several immune populations, relative to their normal counterparts in healthy pancreas. Although granulocytes, B cells, and CD8+ T cells all downregulated oxidative phosphorylation, the mechanisms by which this occurred were cell type specific. In fact, the expression pattern of the electron transport chain complexes was sufficient to identify immune cell types without the use of lineage markers. We also observed changes in tumor-associated macrophage (TAM) lipid metabolism, with increased expression of enzymes mediating unsaturated fatty acid synthesis and upregulation in cholesterol export. Concurrently, cancer cells exhibited upregulation of lipid/cholesterol receptor import. We thus identified a potential crosstalk whereby TAMs provide cholesterol to cancer cells. We suggest that this may be a new mechanism boosting cancer cell growth and a therapeutic target in the future.

Authors

Monica E. Bonilla, Megan D. Radyk, Matthew D. Perricone, Ahmed M. Elhossiny, Alexis C. Harold, Paola I. Medina-Cabrera, Padma Kadiyala, Jiaqi Shi, Timothy L. Frankel, Eileen S. Carpenter, Michael D. Green, Cristina Mitrea, Costas A. Lyssiotis, Marina Pasca di Magliano

×

Figure 3

Downregulation of oxidative phosphorylation in immune cells.

Options: View larger image (or click on image) Download as PowerPoint
Downregulation of oxidative phosphorylation in immune cells.
(A) Schemat...
(A) Schematic of electron transport chain (ETC). (B–D) GSEA enrichment plots demonstrating oxidative phosphorylation is significantly downregulated in CD8+ T cells, B cells, and granulocytes derived from PDA samples, compared with healthy human pancreas tissue, with corresponding NES and adjusted P values. (E) PCA visualization based on the expression of genes driving complex I in B cells, granulocytes, and CD8+ T cells in healthy human and PDA samples. (F–I) Dot plot visualization based on the average expression and percentage of cells expressing genes driving complexes I, II, III, and IV, respectively, in B cells, granulocytes, and CD8+ T cells in healthy human (black) and PDA samples (purple). (J) PCA visualization based on the expression of genes driving ATP synthase in B cells, granulocytes, and CD8+ T cells in healthy human and PDA samples. (K) Dot plot visualization of cells expressing ATP synthase–related genes and percentage expressing these genes in immune cells from tumor tissue (purple) and healthy tissue (black).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts